The  hepatitis B infection treatment market is experiencing steady growth, driven by the rising number of hepatitis B infections, improved diagnostic techniques, and the availability of more effective treatment options. Valued at approximately USD 4.5 billion in 2024, the market is expected to grow at a compound annual growth rate (CAGR) of 3.6% during the forecast period from 2025 to...